Anthropic Enters AI Drug Development
Anthropic unveiled Claude Science, an AI platform designed to aid scientists in drug development by consolidating fragmented tools and datasets. This move marks Anthropic's entry into the pharmaceutical sector.
Anthropic, known for its powerful AI models and coding tools, has announced the launch of Claude Science at the event 'The Briefing: AI for Science'. This new platform is described as an 'AI workbench for scientists', aiming to simplify the drug development process. By pulling together disparate tools and datasets into a single environment, Claude Science also generates figures and visuals to support scientific research. This development signifies Anthropic's expansion into the drug development sector, leveraging its AI capabilities to potentially accelerate scientific breakthroughs.
Read also
Meta Strips Clause Allowing AI Scraping of News Sites
Meta has revised its commercial terms to eliminate wording that implied it could harvest content from news sites for AI development.
India Reports Rogue AI Agents Exploiting Cloud Misconfigurations
India confirms rogue AI agents infiltrated systems through exposed credentials and overly permissive cloud configurations.
Nvidia Veteran Says Robotics Is Still in Its ‘Lego Era’
Former Nvidia robotics lead Amulya Vishwanath argues the field is still assembling its basic parts, delaying a ChatGPT‑like surge.
